0001415889-23-011382.txt : 20230721 0001415889-23-011382.hdr.sgml : 20230721 20230721163009 ACCESSION NUMBER: 0001415889-23-011382 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230719 FILED AS OF DATE: 20230721 DATE AS OF CHANGE: 20230721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mei Baisong CENTRAL INDEX KEY: 0001938499 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 231102825 MAIL ADDRESS: STREET 1: C/O EDITAS MEDICINE, INC. STREET 2: 1 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 form4-07212023_040701.xml X0508 4 2023-07-19 0001650664 Editas Medicine, Inc. EDIT 0001938499 Mei Baisong C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 false true false false SVP, CHIEF MEDICAL OFFICER 1 Common Stock 2023-07-19 4 S 0 4317 8.80 D 72055 D Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2023. The sale does not represent a discretionary trade by the Reporting Person. /s/ Baisong Mei 2023-07-21